M Dalaker

427 total citations
7 papers, 298 citations indexed

About

M Dalaker is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, M Dalaker has authored 7 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Dermatology, 3 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in M Dalaker's work include Psoriasis: Treatment and Pathogenesis (3 papers), Dermatologic Treatments and Research (2 papers) and Laser Applications in Dentistry and Medicine (2 papers). M Dalaker is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (3 papers), Dermatologic Treatments and Research (2 papers) and Laser Applications in Dentistry and Medicine (2 papers). M Dalaker collaborates with scholars based in Norway and United States. M Dalaker's co-authors include Lars O. Svaasand, G Volden, L. T. Norvang, G. Kopstad, J. Stuart Nelson, Lise L. Randeberg, Elisanne J. Fiskerstrand, L Bjermer, Pål Kristian Selbo and Berit Johansen and has published in prestigious journals such as British Journal of Dermatology, Lasers in Surgery and Medicine and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

M Dalaker

6 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Dalaker Norway	6	179	108	73	66	47	7	298
Paolo Bonan Italy	12	328 1.8×	107 1.0×	100 1.4×	8 0.1×	26 0.6×	41	437
Karen H. Kim United States	9	295 1.6×	59 0.5×	175 2.4×	12 0.2×	29 0.6×	14	403
Zaid F. Jasim United Kingdom	8	254 1.4×	36 0.3×	115 1.6×	23 0.3×	13 0.3×	14	317
Sean A. Sukal United States	8	346 1.9×	92 0.9×	84 1.2×	4 0.1×	35 0.7×	17	421
Priscila Giavedoni Spain	9	79 0.4×	12 0.1×	30 0.4×	18 0.3×	10 0.2×	59	222
C. Castillo-Gallego Spain	11	109 0.6×	13 0.1×	37 0.5×	59 0.9×	6 0.1×	22	497
S. Lischner Germany	11	136 0.8×	12 0.1×	23 0.3×	22 0.3×	22 0.5×	24	354
Shigehiko Kuribayashi Japan	11	375 2.1×	57 0.5×	265 3.6×	9 0.1×	15 0.3×	21	480
Robert G. Fante United States	9	111 0.6×	88 0.8×	100 1.4×	9 0.1×	6 0.1×	21	403
Anna Lis‐Święty Poland	13	219 1.2×	30 0.3×	58 0.8×	7 0.1×	28 0.6×	62	401

Countries citing papers authored by M Dalaker

Since Specialization

Citations

This map shows the geographic impact of M Dalaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Dalaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Dalaker more than expected).

Fields of papers citing papers by M Dalaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Dalaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Dalaker. The network helps show where M Dalaker may publish in the future.

Co-authorship network of co-authors of M Dalaker

This figure shows the co-authorship network connecting the top 25 collaborators of M Dalaker. A scholar is included among the top collaborators of M Dalaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Dalaker. M Dalaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Sæterdal, Ingvil, et al.. (2018). TNF-α Inhibitors and Efalizumab for the Treatment of Skin Diseases. Europe PMC (PubMed Central).

2.

Dalaker, M, et al.. (2008). Long‐term maintenance treatment of moderate‐to‐severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort. Journal of the European Academy of Dermatology and Venereology. 23(3). 277–282. 31 indexed citations

3.

Randeberg, Lise L., et al.. (2004). Methemoglobin formation during laser induced photothermolysis of vascular skin lesions. Lasers in Surgery and Medicine. 34(5). 414–419. 84 indexed citations

4.

Dalaker, M. (1999). Expression of the Psoriasis-associated Antigen, Pso p27, is Inhibited by Cyclosporin A. Acta Dermato Venereologica. 79(4). 281–284. 10 indexed citations

5.

Andersen, Sonja, L Bjermer, Pål Kristian Selbo, M Dalaker, & Berit Johansen. (1996). Extracellular phospholipase A2 expression in sarcoidosis.. Lund University Publications (Lund University). 13(1). 70–6. 7 indexed citations

6.

Fiskerstrand, Elisanne J., Lars O. Svaasand, G. Kopstad, et al.. (1996). Laser treatment of port wine stains: therapeutic outcome in relation to morphological parameters. British Journal of Dermatology. 134(6). 1039–1043. 100 indexed citations

7.

Svaasand, Lars O., et al.. (1996). Laser treatment of port wine stains: therapeutic outcome in relation to morphological parameters. British Journal of Dermatology. 134(6). 1039–1043. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact